Literature DB >> 31125536

Effects of sarcopenia, body mass indices, and sarcopenic obesity on diastolic function and exercise capacity in Koreans.

Mi-Hyang Jung1, Sang-Hyun Ihm2, Sang Min Park1, Hae Ok Jung3, Kyung-Soon Hong1, Sang Hong Baek3, Ho-Joong Youn3.   

Abstract

AIMS: Obesity induces left ventricular diastolic dysfunction and ultimately causes heart failure. Sarcopenic obesity is common in heart failure with preserved ejection fraction (HFpEF). However, the precise mechanism by which sarcopenic obesity is related to HFpEF is poorly understood. We aimed to evaluate the combined effect of sarcopenia (SP) and obesity on left ventricular diastolic function and exercise capacity.
METHODS: This study included 733 healthy subjects who underwent health check-ups in a tertiary hospital in Korea. All participants were categorized into four groups: non-SP/non-obese, SP/non-obese, non-SP/obese, and SP/obese. Comprehensive echocardiography with cardiopulmonary exercise testing was performed. Diastolic dysfunction was defined as an E/e' ratio ≥ 10.
RESULTS: Across SP and obesity groups, a gradual decrease in e' velocity and an increase in the E/e' ratio was noted after adjustment for age and sex. Furthermore, a gradual decrease in percent-predicted peak VO2 was observed across the groups. In the multivariate logistic regression analysis, the SP/obese group had the highest risk for diastolic dysfunction (OR 4.27, 95% CI 2.41-7.57), followed by the non-SP/obese group (OR 2.88, 95% CI 1.57-5.29) and the SP/non-obese group (OR 1.90, 95% CI 1.01-3.56) compared with the reference (non-SP/non-obese) group even after controlling for various confounders.
CONCLUSION: Sarcopenic obesity was associated with impaired diastolic function and decreased exercise capacity, suggesting a possible mechanism by which sarcopenic obesity contributes to the development of HFpEF.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diastole; Exercise tolerance; Heart failure; Obesity; Sarcopenia

Mesh:

Year:  2019        PMID: 31125536     DOI: 10.1016/j.metabol.2019.05.007

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  4 in total

Review 1.  Lifestyle Interventions with a Focus on Nutritional Strategies to Increase Cardiorespiratory Fitness in Chronic Obstructive Pulmonary Disease, Heart Failure, Obesity, Sarcopenia, and Frailty.

Authors:  Hayley Billingsley; Paula Rodriguez-Miguelez; Marco Giuseppe Del Buono; Antonio Abbate; Carl J Lavie; Salvatore Carbone
Journal:  Nutrients       Date:  2019-11-21       Impact factor: 5.717

2.  Prevalence and risk factors of stroke-related sarcopenia at the subacute stage: A case control study.

Authors:  Ruihong Yao; Liqing Yao; Amin Rao; Jibing Ou; Wenli Wang; Qinzhi Hou; Chunyan Xu; Bu-Lang Gao
Journal:  Front Neurol       Date:  2022-08-08       Impact factor: 4.086

Review 3.  Sarcopenic Obesity in Heart Failure With Preserved Ejection Fraction.

Authors:  Danielle L Kirkman; Natalie Bohmke; Hayley E Billingsley; Salvatore Carbone
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-30       Impact factor: 5.555

Review 4.  Multimodal Imaging and Biomarkers in Cardiac Amyloidosis.

Authors:  Mi-Hyang Jung; Suyon Chang; Eun Ji Han; Jong-Chan Youn
Journal:  Diagnostics (Basel)       Date:  2022-03-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.